Tofersen Uses, Dosage, Side Effects and more
Tofersen is under investigation in clinical trial NCT03764488 (A Study to Evaluate Safety, Tolerability, and Distribution of a Microdose of Radiolabeled BIIB067 (99mTc-MAG3-BIIB067) Co-administered With BIIB067 to Healthy Adults).
| Attribute | Details |
|---|---|
| Trade Name | Tofersen |
| Generic | Tofersen |
| Tofersen Other Names | Tofersen |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
